Literature DB >> 10932259

A rare complication of adjustable gastric banding: Wernicke's encephalopathy.

A Bozbora1, H Coskun, S Ozarmagan, Y Erbil, N Ozbey, Y Orham.   

Abstract

BACKGROUND: Wernicke's encephalopathy is an uncommon complication seen after morbid obesity surgery. Neurological and cardiac symptoms can occur. Early and adequate replacement of thiamin is crucial.
METHODS: A patient, who was operated by adjustable silicone gastric banding had severe vomiting 1 week after the operation. Physical examination showed no abnormalities except neurological signs consisting of ataxia, disorientation and diplopia. All radiological and biochemical parameters were in the normal range. RESULT: After replacement of vitamin B1 (thiamin) intravenously 20 mg twice daily, all the neurological signs regressed day by day. Oral thiamin pills have been continued.
CONCLUSION: Wernicke's encephalopathy which occurs as a result of thiamin deficiency is a rare complication that has serious morbidity with rapidly progressing neurologic symptoms, and must be treated immediately. Surgeons who treat morbidly obese patients must follow the metabolic and nutritional status of the patient.

Entities:  

Mesh:

Year:  2000        PMID: 10932259     DOI: 10.1381/096089200321643610

Source DB:  PubMed          Journal:  Obes Surg        ISSN: 0960-8923            Impact factor:   4.129


  11 in total

Review 1.  Nutritional deficiencies after bariatric surgery.

Authors:  D J Davies; J M Baxter; J N Baxter
Journal:  Obes Surg       Date:  2007-09       Impact factor: 4.129

2.  Wernicke's encephalopathy after laparoscopic Roux-en-Y gastric bypass: a misdiagnosed complication.

Authors:  Antonio Iannelli; Pietro Addeo; Sebastien Novellas; Jean Gugenheim
Journal:  Obes Surg       Date:  2010-11       Impact factor: 4.129

Review 3.  Nutritional deficiencies in obesity and after bariatric surgery.

Authors:  Stavra A Xanthakos
Journal:  Pediatr Clin North Am       Date:  2009-10       Impact factor: 3.278

4.  Wernicke's syndrome after sleeve gastrectomy.

Authors:  Wojciech Makarewicz; Lukasz Kaska; Jarek Kobiela; Tomasz Stefaniak; Jacek Krajewski; Marta Stankiewicz; Magdalena A Wujtewicz; Andrzej J Lachinski; Zbigniew Sledzinski
Journal:  Obes Surg       Date:  2007-05       Impact factor: 4.129

5.  Peripheral neuropathy and severe malnutrition following duodenal switch.

Authors:  Erlend T Aasheim; Dag Hofsø; Jøran Hjelmesaeth; Rune Sandbu
Journal:  Obes Surg       Date:  2008-05-08       Impact factor: 4.129

6.  Unusual late-onset Wernicke's encephalopathy following vertical banded gastroplasty.

Authors:  María Victoria Velasco; Ignacio Casanova; Andrés Sanchez-Pernaute; Elia Pérez-Aguirre; Antonio Torres; Jesus Puerta; Lucio Cabrerizo; Miguel A Rubio
Journal:  Obes Surg       Date:  2009-05-05       Impact factor: 4.129

7.  Metabolic complications of bypass surgery for morbid obesity.

Authors:  S Richard-Devantoy; J B Garré; B Gohier
Journal:  Clin Med Case Rep       Date:  2009-09-18

8.  Nutritional and Protein Deficiencies in the Short Term following Both Gastric Bypass and Gastric Banding.

Authors:  Judith Aron-Wisnewsky; Eric O Verger; Carine Bounaix; Maria Carlota Dao; Jean-Michel Oppert; Jean-Luc Bouillot; Jean-Marc Chevallier; Karine Clément
Journal:  PLoS One       Date:  2016-02-18       Impact factor: 3.240

9.  Delayed diagnosis of Wernicke encephalopathy with irreversible neural damage after subtotal gastrectomy for gastric cancer: A case of medical liability?

Authors:  Pamela Tozzo; Luciana Caenazzo; Daniele Rodriguez; Matteo Bolcato
Journal:  Int J Surg Case Rep       Date:  2016-12-01

10.  Practical Recommendations of the Obesity Management Task Force of the European Association for the Study of Obesity for the Post-Bariatric Surgery Medical Management.

Authors:  Luca Busetto; Dror Dicker; Carmil Azran; Rachel L Batterham; Nathalie Farpour-Lambert; Martin Fried; Jøran Hjelmesæth; Johann Kinzl; Deborah R Leitner; Janine M Makaronidis; Karin Schindler; Hermann Toplak; Volkan Yumuk
Journal:  Obes Facts       Date:  2017-12-06       Impact factor: 3.942

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.